• SAG Workflows for Hedgehog Pathway Research

  2026-08-29

  SAG enables controlled Smoothened receptor agonism for pathway assays, neural repair models, mitochondrial studies, and developmental biology. This guide connects practical dosing and assay design with orthogonal readouts, reference-study insights, and troubleshooting strategies.

• Acetylspiramycin Workflow for Resistance Research

  2026-08-28

  Acetylspiramycin, or Spiramycin B, supports controlled studies of ribosomal inhibition, macrolide resistance, and host-pathogen interactions. This practical guide connects solvent handling, broth microdilution susceptibility testing, biosynthetic quality control, and troubleshooting to help researchers generate more reproducible data.

• Capillarisenol C and ER Stress-Dependent Autophagy

  2026-08-28

  The reference study identifies capillarisenol C, a bisphenol isolated from Artemisia capillaris, as a cytotoxic compound that suppresses liver cancer cell viability through an ER stress-associated autophagic death program. Its use of autophagy inhibition, ATG7 knockdown, ER stress signaling analysis, and 4-PBA rescue provides a mechanistic framework for distinguishing cytotoxic autophagy from apoptosis.

• Annexin V-APC/7-AAD Apoptosis Kit Guide

  2026-08-27

  The Annexin V-APC/7-AAD Apoptosis Kit is an apoptosis detection kit that combines phosphatidylserine recognition with membrane-integrity staining. Its dual-parameter readout supports rapid apoptosis and necrosis detection by flow cytometry or fluorescence microscopy.

• N1-Methylpseudouridine for mRNA Translation

  2026-08-27

  N1-Methylpseudouridine is a modified nucleoside for mRNA translation enhancement and protein-expression studies. A cited preprint found that combining this modification with GC3 codon optimization produced approximately 1,000-fold greater luciferase potency than wild-type, unmodified mRNA, while product information reports high solvent solubility and research-use validation.

• β-Elemene: AMPK, Apoptosis & Research Use

  2026-08-26

  β-Elemene, also called Levo-β-elemene, is a natural sesquiterpene used in apoptosis, inflammation, neuroprotection, and metabolic research. A 2025 3T3-L1 study found that β-Elemene reduced MDI-induced adipogenesis, improved glucose consumption in an insulin-resistance model, and restored AMPK pathway activity.

• Flexible Phage Surfaces for Rare CTC Subtyping

  2026-08-26

  The reference study shows that mechanically flexible M13 bacteriophages can improve circulating tumor cell capture while suppressing nonspecific white blood cell adsorption. By combining aptamer-functionalized phage nanofibers, magnetic isolation, and immunostaining, the authors achieved strong discrimination between breast cancer patients and healthy donors and supported cancer subtype assignment.

• TLS, TRAF2 Competition, and B-Cell Activation in ESCC

  2026-08-25

  The 2025 Cancer Gene Therapy study links tertiary lymphoid structures with favorable survival in treatment-naïve esophageal squamous cell carcinoma and identifies IRF4-positive B-cell activation as a mechanistic feature. Its central finding is that CD40 and STING compete for TRAF2, coordinating non-canonical NF-κB signaling, STING modification, and IRF4 expression.

• Latent HIV-1, Telomeres, and DNA Damage Vulnerability

  2026-08-25

  The 2018 study by Piekna-Przybylska and Maggirwar shows that HIV-1 infection and latency are associated with telomere elongation in memory CD4+ T cells, while simultaneously increasing sensitivity to telomere-targeting agents. Its findings connect HIV reservoir persistence with altered DNA damage response capacity and suggest a mechanistic basis for selectively stressing infected cells.

• AO/PI and the Translational Logic of Kidney Injury

  2026-08-24

  How AO/PI Staining Solution connects membrane integrity, mechanistic nephropathy research, and more reproducible translational decisions in diabetic kidney disease models.

• Bedaquiline in Viability and TB Assays

  2026-08-23

  This scenario-based guide explains how Bedaquiline (SKU B3492) can support reproducible tuberculosis and cancer-cell experiments while avoiding metabolic-assay misinterpretation. It connects formulation, exposure design, orthogonal readouts, and host-directed tuberculosis research for practical laboratory decision-making.

• NAT1–ENO1–Lactate Axis in Colorectal Cancer

  2026-08-22

  A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, patient, cellular, and mouse-model evidence provides a mechanistic rationale for testing lactate-pathway perturbation alongside immune checkpoint blockade, while remaining preclinical.

• hiPSC Intestinal Organoids for Pharmacokinetic Studies

  2026-08-22

  Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated metabolic and transporter activities, creating a human-relevant platform for pharmacokinetic research.

• PYR-41: E1 Inhibition for Ubiquitination Research

  2026-08-21

  PYR-41 provides an upstream chemical entry point for studying ubiquitin-dependent protein turnover, IκBα stability, inflammatory signaling, and cell survival. This workflow-focused guide explains how to select concentrations, verify E1 engagement, connect results to NF-κB biology, and avoid misinterpreting off-target effects.

• Birinapant (TL32711) in Apoptosis Workflows

  2026-08-20

  Birinapant (TL32711) converts IAP biology into a practical sensitization strategy for apoptosis, TNF signaling, and TRAIL-based cancer assays. This guide connects its mechanism with MDM1–p53 chemoradiotherapy findings and provides workflow parameters, controls, and troubleshooting guidance for translational research.

8534 records 1/569 page Next 12345 下5页 Last page